Malinis, Jaynezamie .
HRN: 26-33-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/08/2024
AMPICILLIN 500MG (VIAL)
12/08/2024
12/14/2024
IVTT
240mg
Q6h
Acute Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Febrile Neutropenia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes